Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2013; 19(35): 5917-5924
Published online Sep 21, 2013. doi: 10.3748/wjg.v19.i35.5917
Table 2 Summary of included studies regarding vitamin D and hepatitis C virus aspects
StudySample sizeHCV genotypeMean viral load log, (UI/mL, average)SVR (n)SVR1 (above/below 30 ng/mL)Previous HCV treatment
Nimer et al[26]50 HCV infected individualsII:28NATreated: 19/2019/23None
III:22Non treated: 23/30
Milazzo et al[25]93 HIV/HCV infected individualsI:665.8 (5.3-6.2)217/14Naïve: 31
Non I:27Non responder or relapser to a previous anti-HCV therapy: 20
Abou-Mouch et al[27]72 HCV infected individualsI:72NATreated: 3131/15None
Non treated: 15
Bitetto et al[20]42 HCV infected individualsI:32Treated: 5 (3-7)Treated: 8/156/7All
Non I:10Non treated: 5 (3-7)Non treated: 5/27
Soumekh et al[28]88 HIV/HCV infected individualsI or IV:77NA136/7All
Non I:11
Reiberg et al[29]84 HIV/HCV infected individualsI:474.5 (1.4-7.6)3911/28None
Non I:37
Jazwinski et al[23]82 HCV infected individualsI:82NA7439/35None
Lange et al[18]468 HCV infected individualsI:3175.9 (2.3-7.7)28017/152None
Terrier et al[22]189 HIV/HCV infected individualsI:845.9 (0-7)619/52None
II or III:73
Other 1
Bitetto et al[21]211 HCV individualsI:955 (2-7)13478/56None
Petta et al[17]196 HCV infected individualsI:1965 (2-8)8226/56None